Jake Lichterman
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- RNA modifications and cancer 2
- Gut microbiota and health 2
- Oncology 4
- Cancer Cells and Metastasis 2
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Sangeetha M. Reddy (1 shared paper)Edwin M. Posadas (5 shared papers)Leland W.K. Chung (5 shared papers)Sajni Josson (3 shared papers)Murali Gururajan (3 shared papers)Yi‐Tsung Lu (4 shared papers)Christopher L. Haga (2 shared papers)Peng Duan (2 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Methods (1 paper)Human Vaccines & Immunotherapeutics (1 paper)Science Immunology (1 paper)Cells (1 paper)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Jake Lichterman
10 papers receiving 730 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 377
- Oncology 287
- Molecular Biology 415
- Immunology 100
- Pulmonary and Respiratory Medicine 142
Countries citing papers authored by Jake Lichterman
This map shows the geographic impact of Jake Lichterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake Lichterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake Lichterman more than expected).
Fields of papers citing papers by Jake Lichterman
This network shows the impact of papers produced by Jake Lichterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake Lichterman. The network helps show where Jake Lichterman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jake Lichterman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 170 | |
| 2 | 2014 | 118 | |
| 3 | 2021 | 99 | |
| 4 | 2013 | 96 | |
| 5 | 2015 | 92 | |
| 6 | 2014 | 82 | |
| 7 | 2023 | 76 | |
| 8 | 2023 | 4 | |
| 9 | 2024 | 1 | |
| 10 | 2017 | 1 |
About Jake Lichterman
Jake Lichterman is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 10 papers that have together received 739 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), RNA modifications and cancer (2 papers), Cancer Cells and Metastasis (2 papers), Cancer-related molecular mechanisms research (2 papers), Gut microbiota and health (2 papers), Immune cells in cancer (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Immune Cell Function and Interaction (1 paper). The work is most often cited by research in Cancer Research (377 citations), Oncology (287 citations), Molecular Biology (415 citations), Immunology (100 citations) and Pulmonary and Respiratory Medicine (142 citations). Jake Lichterman has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Sangeetha M. Reddy, Edwin M. Posadas, Leland W.K. Chung, Sajni Josson, Murali Gururajan, Yi‐Tsung Lu, Christopher L. Haga, Peng Duan, Quanlin Li and Haiyen E. Zhau. Their work appears in journals such as Clinical Cancer Research, Methods, Human Vaccines & Immunotherapeutics, Science Immunology and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.